UBS AG Logo
Login | Preferences | Contact |engita
UBS Fund Gate - Luxembourg
   
Home
News
Products
Compare products
Virtual portfolios
E-mail subscription
General information
 
 
Search for products
Overview
Search by criteria
Product information
UBS products  ›  Product information
UBS ETFs plc - HFRX Global Hedge Fund Index SF UCITS ETF (EUR) A-acc
ISIN no.:  IE00B54DDP56
PDF
PDF
Overview  
Category profile
UBS Exchange Traded Funds offer an investment in a broad-based market with just one transaction, the flexibility of security investments combined with a fund investment and transparency thanks to the reference index.

Fund description
The investment objective of the fund is to deliver the net total return performance of the HFRX Global Hedge fund Index. The stock exchange price may differ from the net asset value.
The fund replicates synthetically the index performance by investing in a swap.
We target to over-collateralise the funds exposure to the swap counterparty by 105%.

Key benefits
Clients benefit from the flexibility of an exchange-traded investment.
Provides access to the performance of the index.
Optimised risk/return profile thanks to a broad diversification across a range of countries.
The fund offers a high degree of transparency, cost efficiency and is easy to trade.
First ETF in the market providing access to the HFR Global Hedge fund Index.

Risks
The fund delivers the return of a broadly diversified hedge fund index and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. The returns payable on the fund are dependant on payments received by the fund from the swap counterparty under the terms of the relevant swap and, therefore, are subject to the credit risk of the swap counterparty. In the event that the swap counterparty defaults under the terms of the relevant swap, the fund may suffer a loss. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund’s assets are passively managed. As a result, the net asset value of the fund’s assets is materially dependent on the performance of the underlying investments. Losses that could be avoided via active management will not be offset.

Product features
Product category
UBS Exchange Traded Funds
UBS ETFs plc
Product domicile
Ireland
Portfolio management
UBS Asset Management
Fund management
Lantern Structured Asset Management Limited
Custodian bank
State Street Custodial Services (Ireland) Limited
Representative for products established under foreign law
UBS Fund Services (Luxembourg) S.A.
Day of inception
October 22, 2010
Currency of account
EUR
Close of financial year
June 30
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Total expense ratio (TER)
0.34% p.a.
Drag Level p.a.
0.34% p.a.
Minimum investment
n.a.
Reference Index / Benchmark
HFRX Global Hedge Fund Index hedged to EUR

Current data
Net asset value
EUR90.72
12/12/2017
High - last 12 months
EUR91.21
06/11/2017
Low - last 12 months
EUR88.99
29/12/2016
Assets of the unit class in mn
EUR38.65
12/12/2017
Total product assets in mn
EUR64.17
12/12/2017

Exchange listing and trading currency
Deutsche Börse (XETRA)
EUR
SIX Swiss Exchange
EUR

Symbols
ISIN no.
IE00B54DDP56
Bloomberg Ticker
HFEUAS SW
Reuters Id
HFEUAS.S

 
Performance chart (EUR-based, as of December 12, 2017)
Indexed, Month-end values
Performance chart (EUR-based, as of December 12, 2017)

Past performance is not a reliable indicator of future results.

Performance (in %, as of December 12, 2017)
in %
1
year
3
years
5
years
ø p.a.
5 years
EUR
1.77
-3.05
-1.96
-0.40
CHF
9.92
-6.02
-5.84
-1.20
USD
12.53
-8.75
-11.54
-2.42
The performance shown does not take account of any commissions, entry or exit charges.
These figures refer to the past. Past performance is not a reliable indicator of future results.
Additional fees (e.g. entry or exit fees) may be charged by the Distributor. Please refer to your financial adviser for more details. For a definition of financial terms refer to the glossary available at www.ubs.com/glossary.
For marketing and information purposes by UBS. Before investing in this product please read the latest prospectus carefully and thoroughly. Prospectuses, simplified prospectuses or Key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS ETF Sicav, 49, Avenue J.F. Kennedy, L-1855, Kirchberg, Luxembourg or from UBS AG, P.O. Box , CH-4002 Basel, Switzerland. The HFRX Global Hedge Fund Index is a trademark of Hedge Fund Research, Inc. and/or HFR Asset Management, LLC (“HFR”) and have been licensed by HFR to UBS solely for use in connection with its Product (“Product”). Other than this license, neither HFR nor the Index (which is complied independently of and without any regard to the Product) have any connection to the Product and have not participated in the Product’s creation and will not participate in it in any manner, including its on-going investment decisions and other administration and sales. The Product is not sponsored, endorsed, sold or promoted by HFR. HFR makes no express or implied recommendation, warranty or representation regarding the Product or the advisability of investing in it or its performance, including the results obtained by the Product. HFR has no obligation to advise the Product or any investor in the Product of any error in the Index. HFR has the right at any time to modify or change the Index, including the methodology used in its calculation, or to discontinue the calculation, publication and dissemination of the Index. HFR shall not be liable to the Product or to any investor in the Product for any damages of any kind or nature, including any error in the Index. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management
Source for all data and charts (if not indicated otherwise): UBS Asset Management
No responsibility is taken for the correctness of the information provided above.

Important legal information - please read the disclaimer before proceeding.
Products and services in these web pages may not be available for residents of certain nations.
Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2017. All rights reserved.
Privacy Policy